Edwards Lifesciences Corporatio with price, financials, news flow, and insider context in one page.
Edwards Lifesciences Corporatio is being tracked here through price action, operating context, and headline flow. This public page covers the latest market move, where EW sits inside Healthcare and Medical Devices, and the key financial markers that matter before moving into a fuller research workflow.
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
This page is structured for research context, not a trade call. It gives you a clean read on where EW sits in its range, what the last few quarters look like, and which headlines are shaping attention.
For position sizing, alerts, saved watchlists, and deeper analysis workflows, the next step is the logged-in Meridian workspace.
| Quarter | Revenue | Net income | Free cash flow |
|---|---|---|---|
| Q4 2025 | 1.57B | 91.2M | 353.5M |
| Q3 2025 | 1.55B | 291.1M | 516.2M |
| Q2 2025 | 1.53B | 329.8M | 240.9M |
| Q1 2025 | 1.41B | 358M | 224.4M |
The rise of increasingly sophisticated AI models is putting pressure on cybersecurity teams to step up their defenses for newer and faster cyberattacks.
There are concerns that a lack of Chinese intervention in the Iran conflict could prompt renewed U.S. military action as early as next week.
(RTTNews) - The Swiss market started off on a firm note on Wednesday and despite a setback around mid-afternoon that pushed it briefly below the flat line, recovered well to end the day's session n...
On 5/15/26, Bridgewater Bancshares Inc's 5.875% Dep Shares Non Cumul Preferred Stock Ser A (Symbol: BWBBP) will trade ex-dividend, for its quarterly dividend of $0.3672, payable on 6/1/26. As a pe...
A public stock page should answer the first research questions before asking for a signup.
This EW page is designed for public research utility. You can read the latest session move, check the one-year chart, review a compact financial table, scan recent headlines, and compare adjacent names without immediately moving into a gated dashboard.
The logged-in Meridian workflow goes further with saved watchlists, deeper analysis, alert routing, and recurring review systems. The public layer is meant to be credible and indexable on its own, not a hollow teaser page.